The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | LAV Biosciences Fund V, L.P. owner | CConversion Series B-1 Preferred Stockderivative | -601,161 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | LAV Biosciences Fund V, L.P. owner | CConversion Series C Preferred Stockderivative | -180,288 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | LAV Biosciences Fund V, L.P. owner | CConversion Series C Preferred Stockderivativeindirect: By LAV Fund VI, L.P. | -360,577 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | LAV Biosciences Fund V, L.P. owner | CConversion Series C Preferred Stockderivativeindirect: By LAV Fund VI Opportunities, L.P. | -360,577 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Common Stockindirect: See Note 2 | +3,334,938 | - | - | 3,334,938 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Common Stockindirect: See Note 2 | +1,113,666 | - | - | 4,448,604 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Common Stockindirect: See Note 2 | +512,897 | - | - | 4,961,501 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Common Stockindirect: See Note 3 | +1,538,691 | - | - | 1,538,691 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Common Stockindirect: See Note 4 | +1,667,468 | - | - | 1,667,468 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Common Stockindirect: See Note 4 | +169,001 | - | - | 1,836,469 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Series B Preferred Stockderivativeindirect: See Note 2 | -3,907,547 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Series B-1 Preferred Stockderivativeindirect: See Note 2 | -1,304,883 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Series C Preferred Stockderivativeindirect: See Note 2 | -600,962 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Series C Preferred Stockderivativeindirect: See Note 3 | -1,802,885 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Series B Preferred Stockderivativeindirect: See Note 4 | -1,953,773 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Sr One Capital Management, LLC owner | CConversion Series B-1 Preferred Stockderivativeindirect: See Note 4 | -198,019 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Common Stockindirect: See Note 2 | +3,334,938 | - | - | 3,334,938 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Common Stockindirect: See Note 2 | +1,113,666 | - | - | 4,448,604 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Common Stockindirect: See Note 2 | +512,897 | - | - | 4,961,501 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Common Stockindirect: See Note 3 | +1,538,691 | - | - | 1,538,691 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Common Stockindirect: See Note 4 | +1,667,468 | - | - | 1,667,468 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Common Stockindirect: See Note 4 | +169,001 | - | - | 1,836,469 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Series B Preferred Stockderivativeindirect: See Note 2 | -3,907,547 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Series B-1 Preferred Stockderivativeindirect: See Note 2 | -1,304,883 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Series C Preferred Stockderivativeindirect: See Note 2 | -600,962 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Series C Preferred Stockderivativeindirect: See Note 3 | -1,802,885 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Series B Preferred Stockderivativeindirect: See Note 4 | -1,953,773 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | Simeon George director, owner | CConversion Series B-1 Preferred Stockderivativeindirect: See Note 4 | -198,019 | $0.00 | $0 | 0 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | John Kent Walker President, Global Affairs, CLO | CConversion Class C Google Stock Units | -4,747 | $0.00 | $0 | 14,329 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | John Kent Walker President, Global Affairs, CLO | CConversion Class C Google Stock Units | -4,258 | $0.00 | $0 | 47,080 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | John Kent Walker President, Global Affairs, CLO | CConversion Class C Google Stock Units | -1,626 | $0.00 | $0 | 56,243 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | John Kent Walker President, Global Affairs, CLO | CConversion Class C Capital Stock | +10,631 | $0.00 | $0 | 22,023 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -121 | $0.00 | $0 | 1,339 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -101 | $0.00 | $0 | 3,548 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -69 | $0.00 | $0 | 4,080 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -105 | $0.00 | $0 | 1,165 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -27 | $0.00 | $0 | 1,587 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -26 | $0.00 | $0 | 934 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -19 | $0.00 | $0 | 1,137 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Google Stock Units | -19 | $0.00 | $0 | 687 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Marsida Saraci VP, Chief Accounting Officer | CConversion Class C Capital Stock | +487 | $0.00 | $0 | 28,362 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Ruth Porat President and CIO | CConversion Class C Google Stock Units | -4,747 | $0.00 | $0 | 14,329 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Ruth Porat President and CIO | CConversion Class C Google Stock Units | -4,258 | $0.00 | $0 | 47,080 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Ruth Porat President and CIO | CConversion Class C Google Stock Units | -1,626 | $0.00 | $0 | 56,243 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Ruth Porat President and CIO | CConversion Class C Capital Stock | +10,631 | $0.00 | $0 | 927,069 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Anat Ashkenazi SVP, Chief Financial Officer | CConversion Class C Google Stock Units | -4,131 | $0.00 | $0 | 12,468 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Anat Ashkenazi SVP, Chief Financial Officer | CConversion Class C Google Stock Units | -4,258 | $0.00 | $0 | 47,080 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Anat Ashkenazi SVP, Chief Financial Officer | CConversion Class C Google Stock Units | -1,765 | $0.00 | $0 | 57,224 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Anat Ashkenazi SVP, Chief Financial Officer | CConversion Class C Capital Stock | +10,154 | $0.00 | $0 | 150,661 | 13 d ago |
| Sep 25, 2026 | GOOGL Alphabet Inc. | Sundar Pichai Chief Executive Officer | CConversion Class C Google Stock Units | -3,671 | $0.00 | $0 | 202,838 | 13 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.